Das, A.; Deka, D.; Baildya, N.; Banerjee, A.; Bisgin, A.; Adhikari, S.; Duttaroy, A.K.; Pathak, S. BMAP-27 Peptide Reduces Proliferation and Increases Apoptosis in Primary and Metastatic Colon Cancer Cell Lines. International Journal of Peptide Research and Therapeutics 2023, 29, doi:10.1007/s10989-023-10572-9.
Das, A.; Deka, D.; Baildya, N.; Banerjee, A.; Bisgin, A.; Adhikari, S.; Duttaroy, A.K.; Pathak, S. BMAP-27 Peptide Reduces Proliferation and Increases Apoptosis in Primary and Metastatic Colon Cancer Cell Lines. International Journal of Peptide Research and Therapeutics 2023, 29, doi:10.1007/s10989-023-10572-9.
Das, A.; Deka, D.; Baildya, N.; Banerjee, A.; Bisgin, A.; Adhikari, S.; Duttaroy, A.K.; Pathak, S. BMAP-27 Peptide Reduces Proliferation and Increases Apoptosis in Primary and Metastatic Colon Cancer Cell Lines. International Journal of Peptide Research and Therapeutics 2023, 29, doi:10.1007/s10989-023-10572-9.
Das, A.; Deka, D.; Baildya, N.; Banerjee, A.; Bisgin, A.; Adhikari, S.; Duttaroy, A.K.; Pathak, S. BMAP-27 Peptide Reduces Proliferation and Increases Apoptosis in Primary and Metastatic Colon Cancer Cell Lines. International Journal of Peptide Research and Therapeutics 2023, 29, doi:10.1007/s10989-023-10572-9.
Abstract
BMAP-27 peptide known to exert cytotoxic effects against cancer cells by membrane integrity disruption. In the current investigation, we aimed to study the role of the BMAP-27 peptide in reducing colon cancer cell proliferation and inducing apoptosis. This study utilized both primary and metastatic colon cancer cell lines (SW480 and SW620). Proliferation was measured using CCK-8, and cellular damage was analyzed by lactate dehydrogenase assay. The study assessed apoptosis, cell cycle, and proliferation by measuring the expression of CASPASE3, BAX, BCL-2, TP53, CDK-6, PCNA, Wnt11, AXIN1, and CTNNB1. Additionally, in-silico studies were conducted to determine the binding affinities of BMAP-27 with APC and β-catenin proteins. BMAP-27 peptide reduced colon cancer cell proliferation, upregulated CASPASE3, BAX, TP53, AXIN1 expression, and downregulated BCL-2, CDK-6, PCNA, WNT11, CTNNB1 in both colon cancer cell lines, however, demonstrated higher activity in primary than metastatic colon cancer cells. The molecular dynamic simulation revealed substantial binding affinity of the peptide to adenomatous polyposis coli and β-catenin proteins.BMAP-27 peptide effectively inhibited the proliferation and enhanced apoptosis in the primary than in metastatic colon cancer cells. In-silico findings suggest that BMAP-27 exhibits a strong binding affinity with APC and β-catenin, highlighting its potential role as an anti-colon cancer agent.
Biology and Life Sciences, Biology and Biotechnology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
,
,
